Consultant Colorectal Surgeon at Addenbrooke's Hospital, Cambridge
Nicola Fearnhead was President of the Association of Coloproctology of Great Britain & Ireland in 2019/20
She has been a Consultant Colorectal Surgeon at Addenbrooke’s Hospital, Cambridge since 2006. She studied medicine at Pembroke College, Cambridge and Merton College, Oxford where she was a Rhodes Scholar. Surgical training was undertaken in Bristol and Oxford followed by an International Fellowship in Advanced Colorectal Surgery at the Cleveland Clinic in Ohio during 2005.
Professor Mohammad Ilyas
Professor of Pathology at the University of Nottingham
Mohammad Ilyas is Professor of Pathology at the University of Nottingham. His research encompasses both basic science and translational research. His areas of interest include the molecular pathology of cancer (especially the roles of Wnt signalling, CD24 and TNS4 in tumourigenesis), liquid biopsy testing for cancer surveillance and digital pathology.
Professor Simon Carding
Quadram Institute and the Norwich Medical School at the University East Anglia
Simon works at the Quadram Institute and the Norwich Medical School at the University East Anglia to develop and lead a multidisciplinary Gut Biology and Microbiology Research Programme.
He completed postgraduate work at the Medical Research Council’s Clinical Research Centre then undertook postdoctoral work at New York University School of Medicine and Yale University prior to obtaining a faculty position at the University of Pennsylvania, Philadelphia and developing a research programme focusing on gut biology and immunology. Simon returned to the UK and the University of Leeds to develop a new programme of research focusing on commensal gut bacteria (the microbiota) leading to the development of a Bacteroides drug delivery technology platform for new treatments for GI-related diseases.
Simon relocated to the Quadram Institute and the Norwich Medical School at the University East Anglia to develop and lead a multidisciplinary Gut Biology and Microbiology Research Programme. A current research focus is using microbiota-derived products and microvesicles for boosting natural immunity in at-risk individuals, and for the delivery of therapeutic proteins and vaccine antigens to mucosal sites to treat or prevent autoimmune – or infection-related diseases that target the GI-tract and other organ systems.
Also of interest is the role of the microbiota in mental health and neurodegenerative diseases (the gut-microbiota-brain axis) which includes the MOTION study, a population based longitudinal study in healthy ageing, investigating the relationship between age-associated changes in the intestinal microbiota and declining cognitive function.
Professor Simon Leedham
Professor of Gastroenterology and a Wellcome Senior Research Fellow in Clinical Medicine at the University of Oxford
Simon Leedham is a Professor of Gastroenterology and a Wellcome Senior Research Fellow in Clinical Medicine at the University of Oxford. He is also the Director of the Oxford Centre for Personalised Medicine. His research is into the morphogenic signaling pathways that control the intestinal stem cell in homeostasis, regeneration, and cancer, and he has published more than 60 peer-reviewed papers in journals that include Nature Medicine, Nature Genetics, Gastroenterology and Gut. Simon’s research has been recognised by the United European Gastroenterology Rising Star award in 2010, the British Society of Gastroenterology Francis Avery Jones research prize in 2015, and the CRUK future leaders prize in 2017.
Dr Philip Woodland
Consultant Gastroenterologist at the Royal London Hospital
Dr Philip Woodland is a Consultant Gastroenterologist at the Royal London Hospital and an Honorary Senior Lecturer in Upper GI Disease at Barts and the London School of Medicine and Dentistry. He runs a specialist oesophageal service, and has an active program of translational and clinical research into oesophageal disorders including gastro-oesophageal reflux disease, oesophageal motility disorders and eosinophilic oesophagitis.
Professor Marilena Lozidou
Deputy Director of the Division of Surgery and Interventional Science (SIS) at UCL
Marilena is the Deputy Director of the Division of Surgery and Interventional Science (SIS) at UCL and Head of the SIS Department at the Royal Free campus and Deputy Director of the Division of Surgery and Interventional Science (SIS) at UCL; and Head of the SIS Department at the Royal Free Campus.
After her undergraduate training in Biochemistry (McMasters University, Canada), she moved to the University of Southampton where she obtained her PhD in Solid Tumour Biology and Pharmacology and became lead clinical scientist at the University of Southampton/NHS. She moved to UCL to the academic department of Surgery, and became Head of Department in 2013.
Marilena uses nanotechnology tools in her cancer pharmacology research. Her main focus has been in the field of novel imaging and targeted therapeutics in solid tumours, mainly colorectal cancer, with a focus on the role of the fibrotic cancer stroma. Marilena co-invented tumouroids, 3D in vitro cultures of cancer which mimic the composition and architecture of solid tumours. Tumouroids are being developed as platforms for therapeutics and for stratified medicine.
Marilena is co-Founder and Director of the MSc in Nanotechnology and Regenerative Medicine and the MSc in Surgical and Interventional Sciences.
Professor Charlie Knowles
Consultant Colorectal Surgeon and Professor of Surgery at Barts and the London School of Medicine and Dentistry.
Consultant Colorectal Surgeon and Professor of Surgery at Barts and the London School of Medicine and Dentistry.
Dr Andrew Stagg
Reader in Immunology at the Blizard Institute, Barts and the London School of Medicine and Dentistry
Andy graduated from Birmingham University and completed his PhD at the Medical Research Council’s (MRC), National Institute for Medical Research. He has worked at the MRC’s Clinical Research Unit, the University of Texas Southwestern and Imperial College. He joined Queen Mary University in 2007, his research interests lie in the area of immune regulation in the human intestine, focussing on both health and Inflammatory Bowel Disease (IBD).
Associate Professor of Surgery and Consultant Colorectal Surgeon at the University of Nottingham
Austin is an Associate Professor of Surgery and Consultant Colorectal Surgeon at the University of Nottingham
Consultant Colorectal Surgeon at the Countess of Chester
Dale Vimalachandran is a consultant colorectal surgeon at the Countess of Chester. He is the Northwest Coast SRG lead for surgery and also sits on the NCRI colorectal surgery subgroup and ACPGBI research and audit committees.
He has interests in all aspects of colorectal research and currently runs a translational research programme in locally advanced rectal cancer at the University of Liverpool. He is the local PI in Chester for a number of surgical and oncology studies and is the Chief Investigator of two portfolio studies along with running an international audit. He is a member of the editorial advisory board for Colorectal Disease and also helps write the ACPGBI of the month.
Dale also chairs the DMC and TSC for a number of NIHR surgical studies and is a very keen advocate of trainee led clinical research and has helped establish the regional INSPIRE trainee research programme in the Northwest.
Professor John Northover
Consulting Surgeon, St Mark's Hospital for Intestinal and Colorectal Disorders
John Northover was a surgeon at St Mark’s, retiring several years ago. His main clinical interest was multi-organ resection of advanced primary and recurrent rectal cancer.
He graduated from King’s and went on to train at King’s, The Middlesex and St Mark’s. He worked for his MS thesis in Cape Town, defining the blood supply of the human bile duct in an effect to help resolve the problem of biliary anastomotic breakdown in the early liver transplants at King’s.
When he joined the St Mark’s staff he also became leader of the newly formed ICRF/CRUK Bowel Cancer Unit within St Mark’s. His main research interests were the aetiology and treatment of anal cancer, bowel cancer screening and the design and management of RCTs in bowel cancer. He was a member or Chair of multiple national RCTs in adjuvant therapy. He published almost 200 peer-reviewed papers, multiple chapters, and several books for clinicians and the public.
His main clinical interest was multi-organ resection of advanced primary and recurrent rectal cancer, for which he set up a team of surgeons in six surgical specialties, drawn from across London.
Dr Gabrielle Thorpe
Lecturer in Colorectal & Stoma Care Nursing, University of East Anglia, Norwich
Gabby is a lecturer at the UEA School of Health Sciences and honorary clinical nurse specialist in stoma care at the Norfolk & Norwich University Hospitals NHS Foundation Trust. Gabby is Chair of the Association of Coloproctology Nurses and has interest and experience in qualitative research, which she teaches across all academic levels.
Independent Patient Representative
Azmina is an independent patient representative with over a decade of experience partnering in clinical research, health services research, audit and service improvement within the fields of colorectal surgery and gastroenterology.
She was diagnosed with Crohn’s disease aged 10, and subsequently with surveillance-detected high grade dysplasia aged 25. She lives with a permanent ileostomy further to panproctocolectomy surgery aged 25.
Azmina presently co-chairs the Public and Patient Group (PPG) of the CRUK Bowel Cancer Intelligence Hub programme and serves on American Society of Clinical Oncology (ASCO) Expert Panels for Resource Stratified Guidelines on Colorectal Cancer.
Her most recent collaborations include the National Audit of Small Bowel Obstruction (NASBO), International Consensus on Low Anterior Resection Syndrome (LARS), NIHR GlobalSurg international surgical trials collaborative, LaCeS (emergency laparoscopic vs open abdominal surgery randomized controlled trial; and IBD-BOOST (NIHR-funded programme of interventional studies in Inflammatory Bowel Disease).
Azmina was previously a Trustee of the Bowel Disease Research Foundation, a Trustee of Crohn’s and Colitis UK and a member of the Patient Liaison Group of the ACPGBI.
Clinical Lecturer & Honorary StR in Colorectal Surgery, Dukes' Club President
I am a clinical lecturer and ST8 in Edinburgh Colorectal unit. I undertook a PhD at Edinburgh MRC IGMM in colorectal cancer genetics and vitamin D as a CRC chemopreventive agent.
I spent 2 years as Dukes’ Club reseach and audit representative and it is my desire to improve patient outcomes through translational research that stimulates and motivates me. It is my ambition to work as an academic colorectal surgeon in a busy progressive colorectal unit.
Dr Catherine Boereboom
Dr Catherine Boereboom joined the Trustees of the Bowel Disease Research Foundation, as President of the Dukes Club for colorectal surgery trainees, in 2013 and has worked with the BDRF ever since.
Catherine trained in the East Midlands and completed a PhD in preoperative exercise for colorectal cancer patients.
Catherine works at Queens Medical Centre in Nottingham with a specialist interest in pelvic floor disorders.
Professor Susan Clark
MA MB BChir MD FRCS (Gen Surg),Consultant Colorectal Surgeon, St Mark's Hospital
Professor Sue Clark MD FRCS(Gen Surg) EBSQ(Coloproctology) trained at the University of Cambridge, St Thomas’s Hospital Medical School and in the South West Thames Region, as well as undertaking a period of full time research as an Imperial Cancer Research Fund fellow.
She is a Consultant Colorectal Surgeon at St Mark’s Hospital, Harrow, UK and Professor of Practice (Colorectal Surgery) at Imperial College, London. Additional roles include Director of the St Mark’s Hospital Polyposis Registry, Administrative Officer of the International Society for Gastrointestinal Hereditary Tumours, Royal College of Surgeons of England Genomics Champion and Editor of Colorectal Disease.
She was a member of the Royal College of Surgeons of England Commission on the Future of Surgery. Her main clinical and research interests are colorectal cancer genetics, polyposis syndromes, colorectal cancer biology and ileoanal pouch dysfunction.
Consultant Colorectal Surgeon at the John Goligher Unit in Leeds
Jim Tiernan is Chair of the ACPGBI Research and Audit Committee. He is a Consultant Colorectal Surgeon at the John Goligher Unit in Leeds and Honorary Senior Lecturer in Surgery at the University of Leeds.
He undertook his surgical training throughout Yorkshire, during which he completed a PhD in nanobiotechnology, followed by a fellowship at the Cleveland Clinic, Ohio, USA. His clinical interests include advanced/recurrent colorectal cancer and complex inflammatory bowel disease. He is also the NIHR CRN specialty lead for surgery in Yorkshire & Humber.
Share this page: